GHRH Analogs

Sermorelin vs GHRH-T

Sermorelin and GHRH-T are both growth hormone-releasing hormone (GHRH) analogs, but they differ in length and stability. Sermorelin is the minimal functional GHRH fragment, while GHRH-T is a stabilized full-length analog.

Side-by-Side Comparison

PropertySermorelinGHRH-T
CategoryGHRH(1-29) analog (shortest fully active GHRH fragment)Stabilized full-length GHRH(1-44) analog (trans-3-hexenoyl modification)
Mechanism of ActionBinds GHRH receptor on pituitary somatotrophs; stimulates pulsatile GH secretion in model systemsBinds GHRH receptor; the N-terminal hexenoyl group confers resistance to DPP-4 degradation, extending activity
Molecular Weight~3,358 Da (29 amino acids)~5,136 Da (44 amino acids + hexenoyl moiety)
Research FocusGHRH receptor signaling and GH pulsatility assaysGHRH receptor signaling and peptide stability (DPP-4 resistance) studies
Receptor TargetGHRH receptorGHRH receptor
Half-Life~10-20 minutes~26-38 minutes

Key Differences

  • Sermorelin is the truncated GHRH(1-29) fragment, the shortest sequence retaining full receptor activity; GHRH-T keeps all 44 residues and adds a stabilizing hexenoyl group.
  • GHRH-T’s DPP-4 resistance roughly doubles its half-life relative to sermorelin, though both remain short-acting compared to DAC-modified analogs.
  • Both bind the same GHRH receptor and preserve a pulsatile pattern of GH release in model systems.
  • Research applications differ accordingly: sermorelin appears in GH-axis signaling studies, GHRH-T in peptide stabilization and receptor-binding studies.

Research Summary

Sermorelin and GHRH-T engage the same GHRH receptor but represent different design choices. Sermorelin strips GHRH to its minimal active fragment, producing a short-acting tool for studying GH pulsatility. GHRH-T preserves the full-length sequence and armors it against DPP-4 degradation, yielding a longer-acting analog. Both preserve the natural pulsatile pattern of GH release, distinguishing GHRH analogs from direct GH.

What is the difference between sermorelin and GHRH-T?

Both are GHRH receptor agonists. Sermorelin is the minimal GHRH(1-29) fragment with a ~10-20 minute half-life. GHRH-T is a full-length GHRH(1-44) analog stabilized against DPP-4 degradation, with a longer half-life.

Disclaimer: All compounds referenced on this page are sold for research and laboratory use only. The comparisons presented are based on published scientific literature and are intended for educational and informational purposes. This content does not constitute medical advice. Researchers should consult primary literature and applicable regulations before designing study protocols.